FFECT OF LIRAGLUTIDE ON CARDIOVASCULAR RISK FACTORS AND FUNCTION
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 3
Abstract
Cardiovascular disease is the major cause of death in diabetes. This results from a cluster of risk factors, including high glucose, obesity, hypertension and dyslipidaemia. Liraglutide is the first native GLP-1 analogue and represents a breakthrough approach in type 2 diabetes treatment. Previous data from the LEAD™ programme have shown liraglutide to be a potent glucose regulator, but also to induce weight loss, lower blood pressure, and potentially show improvements in lipid levels, amongst other markers of cardiovascular risk. GLP-1 has also been shown to have an effect on the renal system, as well as the vascular system. Other cardio-protective effects of GLP-1 were proved in animal models: improves cardiac function in heart failure, functional recovery following myocardial ischemia, endothelium dysfunction, increases myocardial glucose uptake and reduces infarct size. Cardiovascular safety of liraglutide was assessed using existing clinical data. The incidence ratio for adjudicated broad/serious major adverse cardiovascular events (MACE) associated with liraglutide was 0.73 (95% CI 0.38–1.41) versus all comparator drugs, within cardiovascular safety limits defined by the United States Food & Drug Administration.
Authors and Affiliations
Maria Mota, Emiliana Mocan, Sorina Botescu
Keywords
Related Articles
- EP ID EP113933
- DOI -
- Views 115
- Downloads 0
A SENSITIVE METHOD FOR DETECTING DINUCLEOTIDE ISLANDS AND CLUSTERS THROUGH DEPTH ANALYSIS
The field of bioinformatics is an essential asset for modern biology. In recent years, after the appearance of GWS (Genome Wide Scan) studies, powerful bioinformatics methods have been developed. In order to understand t...
NC Paulescu’s “Traite de Physiologie Medicale”
SLEEPING WITH THE ENEMY
REMISSION PERIOD IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES
Type 1 diabetes mellitus (DM) is characterized by a progressive autoimmune destruction of pancreatic beta cells, process that can be influenced by clinical and metabolic factors. The objective was to identify those facto...
FISH CONSUMPTION AND THE RISK OF TYPE 2 DIABETES
It is currently estimated that 285 million people suffer from diabetes in the world and by the year 2025 will be double. Diabetes mellitus appears to confer an excess risk of cardiovascular disease and premature death. A...